個人化醫療的概念與專利－本土藥廠的藥品專利困境為中心

The Correlation between the Concept of Personalized Medicine with Patent-Centered on the Plight of Patent Issues toward the Pharteutical Companies in Taiwan

陳偉熹(Wei-Hsi Chen) ； 周敏雄(Min-Shon Chou) ； 陳順勝(Shun-Sheng Chen) ； 崔智(Chi Tsui) ； 蘇清泉(Ching-Chyuan Su) ； 莊維周(Wei-Chou Chuan) ； 程法彰(Fa-Chang Cheng)

《安泰醫護雜誌》 14卷3期 (2008/10) Pp. 123-135

https://doi.org/10.7078/TSMHMNJN.200810.0123

摘要

由於科學進步和基因體研究已經逐漸成熟，在人類追求更高之健康品質的慾望下，驅使個人化醫療之時代已經來臨。個人化醫療之精神強調以正確之方法用在正確之病人身上。在這樣的前題下，針對個人不同體質而選擇不同藥品的治療模式亦是目前醫療的趨勢。我國本土藥廠在學名藥品的製造販售上，往往受限於藥證制度以及專利制度兩者的規範而無法充分發揮其功能。本文即以個人化醫療的角度出發，探討專利制度（甚至包含營業秘密）對於我國學名藥廠的影響，藉此說明我國本土藥廠所面臨的困境，最後建議我國應加強投入專利藥品的研發作為因應。

關鍵字

個人化醫療 ； 專利 ； 本土藥廠 ； 學名藥 ； 基因體 ； 藥品市場 ； 營業秘密 ； 醫療 ； 健康

並列摘要

Scientific promotion, maturity of genomic study, and desire of a better health quality in human accelerate the personalized medication. The fundamental basis of personalized medication is to use the right medicine in right man. Under this proposition, medical treatment based upon different physical characters by different medicine is the current tendency. The pharmaceutical companies in Taiwan are generally producing generic drugs. Our pharmaceutical companies are restrained on the manufacture and sale of their products by the system of medicine license issued by the government agency and the system of patent and cannot wholly fulfill their function. This article is through the prospective of personalized medication discussing the effects of the protection of patent rights (even trade secrets) to our pharmaceutical companies producing generic medicine, explaining the predicament they are encountering. And last, the conclusion is to suggest our government to response by increasingly involving in the research and development for patent drugs as the solution to the problems mentioned before.

並列關鍵字

personalized medicine ； patent ； domestic pharmaceuticals ； generic drug ； genome ； drug market ； trade secret ； medical service ； health